These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 20375419)

  • 21. Long-term health outcomes of a decision aid: data from a randomized trial of adjuvant! In women with localized breast cancer.
    Vickers AJ; Elkin EB; Peele PB; Dickler M; Siminoff LA
    Med Decis Making; 2009; 29(4):461-7. PubMed ID: 19270108
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adjuvant therapy for breast cancer.
    NIH Consens Statement; 2000 Nov 1-3; 17(4):1-35. PubMed ID: 11512506
    [TBL] [Abstract][Full Text] [Related]  

  • 23. When Does the Incremental Risk Format Aid Informed Medical Decisions? The Role of Learning, Feedback, and Number of Treatment Options.
    Tiede KE; Ripke F; Degen N; Gaissmaier W
    Med Decis Making; 2020 Feb; 40(2):212-221. PubMed ID: 32036764
    [No Abstract]   [Full Text] [Related]  

  • 24. Tailoring risk communication to improve comprehension: Do patient preferences help or hurt?
    Barnes AJ; Hanoch Y; Miron-Shatz T; Ozanne EM
    Health Psychol; 2016 Sep; 35(9):1007-16. PubMed ID: 27183307
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Health-related quality of life in early breast cancer.
    Groenvold M
    Dan Med Bull; 2010 Sep; 57(9):B4184. PubMed ID: 20816024
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Calibration and discriminatory accuracy of prognosis calculation for breast cancer with the online Adjuvant! program: a hospital-based retrospective cohort study.
    Mook S; Schmidt MK; Rutgers EJ; van de Velde AO; Visser O; Rutgers SM; Armstrong N; van't Veer LJ; Ravdin PM
    Lancet Oncol; 2009 Nov; 10(11):1070-6. PubMed ID: 19801202
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of Unblinding on Participants' Perceptions of Risk and Confidence in a Large Double-Blind Clinical Trial of Chemotherapy for Breast Cancer.
    Partridge AH; Sepucha K; O'Neill A; Miller KD; Motley C; Swaby RF; Schneider BP; Dang CT; Northfelt DW; Sledge GW
    JAMA Oncol; 2015 Jun; 1(3):369-74. PubMed ID: 26114161
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Communicating tailored risk information of cancer treatment side effects: Only words or also numbers?
    Vromans RD; Pauws SC; Bol N; van de Poll-Franse LV; Krahmer EJ
    BMC Med Inform Decis Mak; 2020 Oct; 20(1):277. PubMed ID: 33109175
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Animated randomness, avatars, movement, and personalization in risk graphics.
    Witteman HO; Fuhrel-Forbis A; Wijeysundera HC; Exe N; Dickson M; Holtzman L; Kahn VC; Zikmund-Fisher BJ
    J Med Internet Res; 2014 Mar; 16(3):e80. PubMed ID: 24642037
    [TBL] [Abstract][Full Text] [Related]  

  • 30. LHRH agonists for adjuvant therapy of early breast cancer in premenopausal women.
    Sharma R; Hamilton A; Beith J
    Cochrane Database Syst Rev; 2008 Oct; (4):CD004562. PubMed ID: 18843661
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The impact of home care nurses' numeracy and graph literacy on comprehension of visual display information: implications for dashboard design.
    Dowding D; Merrill JA; Onorato N; Barrón Y; Rosati RJ; Russell D
    J Am Med Inform Assoc; 2018 Feb; 25(2):175-182. PubMed ID: 28460091
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A decision aid to assist in adjuvant therapy choices for breast cancer.
    Siminoff LA; Gordon NH; Silverman P; Budd T; Ravdin PM
    Psychooncology; 2006 Nov; 15(11):1001-13. PubMed ID: 16511899
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Offering a choice between two adjuvant chemotherapy regimens: a pilot study to develop a decision aid for women with breast cancer.
    Irwin E; Arnold A; Whelan TJ; Reyno LM; Cranton P
    Patient Educ Couns; 1999 Jul; 37(3):283-91. PubMed ID: 14528554
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Picture This: Presenting Longitudinal Patient-Reported Outcome Research Study Results to Patients.
    Tolbert E; Brundage M; Bantug E; Blackford AL; Smith K; Snyder C;
    Med Decis Making; 2018 Nov; 38(8):994-1005. PubMed ID: 30132393
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dissemination of adjuvant multiagent chemotherapy and tamoxifen for breast cancer in the United States using estrogen receptor information: 1975-1999.
    Mariotto AB; Feuer EJ; Harlan LC; Abrams J
    J Natl Cancer Inst Monogr; 2006; (36):7-15. PubMed ID: 17032888
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Benefits and harms of selective oestrogen receptor modulators (SERMs) to reduce breast cancer risk: a cross-sectional study of methods to communicate risk in primary care.
    McIntosh JG; Minshall J; Saya S; Bickerstaffe A; Hewabandu N; Qama A; Emery JD
    Br J Gen Pract; 2019 Dec; 69(689):e836-e842. PubMed ID: 31636127
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assessment of pictographs developed through a participatory design process using an online survey tool.
    Kim H; Nakamura C; Zeng-Treitler Q
    J Med Internet Res; 2009 Feb; 11(1):e5. PubMed ID: 19275981
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of a pictograph enhancement system for patient instruction: a recall study.
    Zeng-Treitler Q; Perri S; Nakamura C; Kuang J; Hill B; Bui DD; Stoddard GJ; Bray BE
    J Am Med Inform Assoc; 2014; 21(6):1026-31. PubMed ID: 25301809
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Using Separate Single-Outcome Risk Presentations Instead of Integrated Multioutcome Formats Improves Comprehension in Discrete Choice Experiments.
    Wallace MJ; Weissler EH; Yang JC; Brotzman L; Corriere MA; Secemsky EA; Sutphin J; Johnson FR; Marcos Gonzalez J; Tarver ME; Saha A; Chen AL; Gebben DJ; Malone M; Farb A; Babalola O; Rorer EM; Zikmund-Fisher BJ; Reed SD
    Med Decis Making; 2024 Aug; 44(6):649-660. PubMed ID: 38903012
    [TBL] [Abstract][Full Text] [Related]  

  • 40. National Institutes of Health Consensus Development Conference Statement: adjuvant therapy for breast cancer, November 1-3, 2000.
    Eifel P; Axelson JA; Costa J; Crowley J; Curran WJ; Deshler A; Fulton S; Hendricks CB; Kemeny M; Kornblith AB; Louis TA; Markman M; Mayer R; Roter D
    J Natl Cancer Inst; 2001 Jul; 93(13):979-89. PubMed ID: 11438563
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.